Dehydro Olmesartan Medoxomil is a pharmaceutical impurity related to the antihypertensive drug olmesartan medoxomil. It is characterized as a structural derivative containing an imidazole ring and a tetrazole moiety, with a molecular weight of approximately 540 g/mol and moderate lipophilicity.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 879562-26-2
Olmesartan medoxomil
active pharmaceutical ingredient
1,4-Bis[3,4-dihydro-2(1H)-quinolinon-7-oxy]butane
pharmaceutical impurity
Benzoic acid, 2-(hexahydro-1-methyl-1H-azepin-4-yl)hydrazide
pharmaceutical impurity
4-Chloro-3,5-dimethylphenol
antiseptic drug active ingredient
1-Acetamidoadamantane
pharmaceutical raw material
Cefepime
active pharmaceutical ingredient
Pilsicainide hydrochloride
active pharmaceutical ingredient
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-prop-1-en-2-yl-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate
PSFJJUXSEHXDFN-UHFFFAOYSA-N
CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(=C)C